McAllister Garfield invites you to a free webinar
USDA Hemp Rules: Impacts and Analysis, Q&A
This one-hour webinar will present an overview of the USDA’s Interim Final Rule for Establishment of a Domestic Hemp Production Program and will discuss the benefits and drawbacks of the rule’s impact on the hemp industry. McAllister Garfield hemp chair David Wunderlich will offer a summary and analysis of key provisions of the rule, and will respond to questions from the viewers. Discussion topics include:
- USDA testing and sampling requirements, including Delta-9 THC and THCA testing
- Impact on existing hemp cultivations and extraction businesses
- Interstate transportation issues
- Penalties for violations
- Opportunities for public comments
Thursday, November 21, 2019 | 1:30p.m. to 2:30p.m. (Mountain time)
Presenter
McAllister Garfield Hemp/CBD Chair
Senior Attorney
Register & Submit Questions Here
About McAllister Garfield, P.C.
McAllister Garfield, PC handles all aspects of marijuana and hemp/CBD legal work from start up to exit, including business transactions, entity formation, investment and finance agreements, intellectual property licensing/royalty agreements, civil litigation and regulatory compliance. We also work on merit-based cannabis business applications nationwide. In addition to companies that touch the plant, we also work with many ancillary companies and investors on projects that are national in scope, such as opinion letters on cannabis and hemp legality and 50 state surveys on the current legal status of CBD. Finally, the firm is helping several well-known public companies, private equity funds, and MSOs expand across the country with regulatory compliance and corporate transaction work. The Firm’s primary offices are in Denver and Los Angeles, but also has lawyers licensed in Michigan, Oregon, and New York. For more information, please see our website www.mcallistergarfield.com.
Related Article
Psychedelic Therapy & Law Update – April 2026
President Trump to Issue Executive Order on Ibogaine President Trump will sign an executive order opening doors for more federal reserach on ibogaine, the naturally occuring psychedelic substance with indigenous roots in Africa. For more information, see this article by clicking here. Ibogaine has shown significant benefits for veterans suffering from war trauma, those suffering from […]
Psychedelic Therapy & Law Update – March 2026
Colorado starts the rulemaking process again for NMHA program changes DOR Natural Medicine Division is proposing several rules changes to the NMHA rules. These proposed changes include a significant increase in the cost of standard healing center licenses (from $6k to over $10k). Other proposed changes include adding an owner entity fee, prohibiting cultivator sampling […]
Psychedelic Therapy & Law Update – February 2026
Maryland and New Jersey moving toward creation of psilocybin programs The Maryland Task Force on Responsible Use of Natural Psychedelic Substances, in a report near the end of 2025 endorsed the creation of a regulated psilocybin program in the state. The recommendation still needs to be adopted by the Maryland legislature, but this is an […]